Linda Best

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
    Am J Gastroenterol 100:1477-88. 2005
  2. ncbi Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta T6G 2X8, Canada
    Gut 57:723-4. 2008
  3. ncbi Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review
    Sander Jo van Zanten
    University of Alberta, Edmonton, Alberta, Canada
    Can J Gastroenterol 26:196-204. 2012
  4. ncbi Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study
    S Veldhuyzen van Zanten
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Aliment Pharmacol Ther 34:714-23. 2011
  5. ncbi Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection
    Sander Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Edmonton Centre, Edmonton, Alberta
    Can J Gastroenterol 24:303-6. 2010
  6. ncbi Systematic review of the quality of patient information on the internet regarding inflammatory bowel disease treatments
    Morgan Langille
    Division of Otolaryngology Head and Neck Surgery, University of Alberta, Edmonton, Canada
    Clin Gastroenterol Hepatol 8:322-8. 2010
  7. ncbi Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective?
    Sander Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta, Canada
    Eur J Gastroenterol Hepatol 20:489-91. 2008
  8. ncbi Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire
    S V Van Zanten
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 25:1087-97. 2007
  9. ncbi Design of treatment trials for functional gastrointestinal disorders
    E Jan Irvine
    Division of Gastroenterology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada
    Gastroenterology 130:1538-51. 2006
  10. ncbi Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie Medical School, Dalhousie University, Queen Elizabeth II Health Sciences Centre, 1278 Tower Road, Halifax, Nova Scotia B3H 2Y9, Canada
    Can J Gastroenterol 19:285-303. 2005

Collaborators

Detail Information

Publications10

  1. ncbi A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
    Am J Gastroenterol 100:1477-88. 2005
    ..CONCLUSION: Treatment with omeprazole provides superior symptom relief compared to ranitidine, cisapride, and placebo in the treatment of H. pylori negative primary care dyspepsia patients...
  2. ncbi Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta T6G 2X8, Canada
    Gut 57:723-4. 2008
  3. ncbi Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review
    Sander Jo van Zanten
    University of Alberta, Edmonton, Alberta, Canada
    Can J Gastroenterol 26:196-204. 2012
    ..Patient satisfaction is increasingly regarded as an important aspect of measuring treatment success in individuals with gastroesophageal reflux disease (GERD)...
  4. ncbi Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study
    S Veldhuyzen van Zanten
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Aliment Pharmacol Ther 34:714-23. 2011
    ..Patients with dyspepsia often experience troublesome symptoms...
  5. ncbi Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection
    Sander Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Edmonton Centre, Edmonton, Alberta
    Can J Gastroenterol 24:303-6. 2010
    ..To evaluate the efficacy of rescue therapy using rifabutin, amoxicillin and a proton pump inhibitor (PPI) in the eradication of Helicobacter pylori in patients who have failed at least one course of PPI-based triple therapy...
  6. ncbi Systematic review of the quality of patient information on the internet regarding inflammatory bowel disease treatments
    Morgan Langille
    Division of Otolaryngology Head and Neck Surgery, University of Alberta, Edmonton, Canada
    Clin Gastroenterol Hepatol 8:322-8. 2010
    ..A systematic review evaluating the quality of information available for inflammatory bowel disease patients on the Internet regarding treatment options was performed...
  7. ncbi Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective?
    Sander Veldhuyzen van Zanten
    Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta, Canada
    Eur J Gastroenterol Hepatol 20:489-91. 2008
    ..This is certainly recommended when dealing with bleeding ulcers...
  8. ncbi Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire
    S V Van Zanten
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 25:1087-97. 2007
    ..The reflux disease questionnaire (RDQ) is a short, patient-completed instrument...
  9. ncbi Design of treatment trials for functional gastrointestinal disorders
    E Jan Irvine
    Division of Gastroenterology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada
    Gastroenterology 130:1538-51. 2006
    ..Trials should be registered in a public location, prior to initiation, and should be published even if the results are negative or inconclusive...
  10. ncbi Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool
    Sander J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie Medical School, Dalhousie University, Queen Elizabeth II Health Sciences Centre, 1278 Tower Road, Halifax, Nova Scotia B3H 2Y9, Canada
    Can J Gastroenterol 19:285-303. 2005
    ..When starting nonsteroidal anti-inflammatory drugs for a prolonged course, testing and treatment with H2RAs are advised if patients have a history of previous ulcers or ulcer bleeding...